PHI with Acquired immunodeficiency syndrome (AIDS)
How does this condition affect your private health insurance?
Acquired Immunodeficiency Syndrome (AIDS) is the most advanced stage of human immunodeficiency virus (HIV) infection. HIV targets and destroys CD4+ T-cells, critical components of the immune system, leading to severe immunodeficiency. This compromises the body's ability to fight off infections and certain cancers. Without effective treatment, individuals with AIDS are highly susceptible to opportunistic infections, neurological complications, and malignancies. While there is no cure, modern antiretroviral therapy (ART) can effectively manage the virus, prevent the progression to AIDS, and allow individuals to live long, healthy lives, significantly reducing viral load to undetectable levels.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Initial acute retroviral syndrome lasts typically 2-4 weeks; the latent stage can last for 8-10 years before progression to AIDS.
Duration of Illness (Lifetime)
Chronic, lifelong disease requiring continuous management.
Cost of Treatment (Initial)
High, including diagnostic tests (HIV RNA, CD4 count), initial consultations, and commencement of lifelong antiretroviral therapy (ART), potentially several thousand euros.
Cost of Treatment (Lifetime)
Very high, lifelong medication (ART), regular monitoring, and management of opportunistic infections or comorbidities, potentially hundreds of thousands of euros.
Mortality Rate
High without treatment, but significantly reduced (to near general population levels) with effective and consistent antiretroviral therapy.
Risk of Secondary Damages
Very high; encompasses opportunistic infections, certain cancers (e.g., Kaposi's sarcoma, non-Hodgkin lymphoma), neurological complications (HIV-associated neurocognitive disorders), and chronic inflammation leading to cardiovascular, renal, and bone diseases.
Probability of Full Recovery
Extremely low, as HIV infection is currently considered lifelong with no standard cure; ART manages but does not eradicate the virus.
Underlying Disease Risk
High, due to severe immunosuppression; common underlying conditions include opportunistic infections (e.g., Pneumocystis pneumonia, toxoplasmosis, candidiasis), various cancers, and organ dysfunction.